Thu, Oct 23, 2014, 4:50 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Abbott Laboratories Message Board

  • upward2000 upward2000 Oct 17, 2012 11:47 PM Flag

    Hep C Multi-Billion Dollar Market & Growing Fast

    ABT the Leader and Winner--on to $80s in 2013 --Easy

    The regimen with the highest SVR12 rates contained the Abbott experimental drugs--ABT-450 with ritonavir, ABT-267 and ABT-333--plus ribavirin for 12 weeks.

    This regimen led to an SVR12 rate of 99% in 77 patients who hadn't received prior treatment, and 93% among 41 patients who hadn't responded well to therapy containing the injectable drug interferon.

    Read more: http://www.foxbusiness.com/news/2012/10/15/abbott-hepatitis-c-regimen-suppresses-virus-in-new-study/#ixzz29cPMs1ua

    Sentiment: Strong Buy

 
ABT
42.43+0.84(+2.02%)4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.